ConferenceSeries Ltd invites all the participants across the globe to attend the "22nd Global Oncologists Annual Meeting” slated on 22nd Global Annual Oncologists Meeting” during May 24-25 at Osaka, Japan Theme: Welcoming the era of multiplying smiles not Cancer cells Oncologists 2018 directs towards addressing main issues as well as future strategies of Cancer.This is going to be the largest and most promising international conference where the program includes Clinical Oncologists, Registered Nurses, Nurse practitioners and the entire medical team involved in patient care, researchers, professional, early career individuals and patient advocates who wish to learn principles of tumour immunology and immunotherapy well as decision makers will come to discuss and debate on various aspects of the challenges, risks and investment opportunities throughout the complete information of Cancers. Oncologists Meeting at Cologne, Germany will deal with Prevention, Diagnosis, and Treatment diseases of the Organ-related Cancers and its innovative techniques.

1. B
ro
c
h
u
re
conferenceseries.com
Osaka, Japan
May 24-25, 2018
http://annualmeeting.conferenceseries.com/oncologists/
Oncologists
2018
22nd
Global Annual
Oncologists Meeting

2. After the successful completion of 16th
Global Oncologists Annual Meeting Oncologists,
held on April 24-25th, 2017 at Dubai, UAE, which was organised by Conferenceseries
LLC, with immense pleasure we are taking this to invite you all for our upcoming event
thatis22ndGlobalAnnualOncologistsMeeting heldatMay24-25,2018Osaka,Japan.
Conferenceseries LLC welcomes you to attend the International Conference on Cancer
Diagnostics during November 27- 28, 2017 at Dubai, UAE.
We cordially invite all the participants who are interested in sharing their knowledge and
research in the area of Oncologists and related fields. Oncologists 2016 & 2017 anticipates
more than 300 participants around the globe with thought provoking Keynote lectures, Oral
andPosterpresentations.TheattendingdelegatesincludeEditorialBoardMembers ofrelated
International Journals. This is an excellent opportunity for the delegates from Universities
and Institutes to interact with the world class Scientists. The intending participants can
confirm their participation by registering for the conference along with your colleagues. Avail
the delegate early bird offer.
Themainthemeoftheconferenceis“WelcomingtheeraofmultiplyingsmilesnotCancercells”.
Regards,
Oncologists 2018
Operating Committee
Invitation

3. Oncologists 2016 Testmonials
Mohammed Y Almaghrabi, Prince Faisal Cancer Center, Saudi Arabia
It was highly informative meeting. I was surprised with such organization and arrangement. I met some
figures who had inspired me. I came across with a dozen of ideas that can easily implement in clinical
research.
Diana Anderson, University of Bradford, UK
It was a good conference and all the speakers gave very clear presentations.I think this is very worth
full conference.
Sonya Sergieva, Sofia Cancer Center Sofia, Bulgaria
The conference was organized perfectly. I would like to thank organiser for excellent hotel,congress
programme, certificate, materials. Thank you for the warm hospitality.
Jaleel Kareem Ahmed, Babylon University, Iraq
The conference was well arranged , good place , good time , good interval , excellent articles by profes-
sional researchers.
Dr. Alvaro Macieira-Coelho, French National Institute of Health
(INSERM), France
Dr. Alok De, Kansas City VA Medical Center, USA
Dr. Ali Aldameh, Al Zahra cancer centre, UAE
Dr. Humaid O Al-Shamsi, The University of Texas, USA
Dr. Tarek Dufan, American Hospital Dubai, UAE
Dr. Diana Anderson, University of Bradford, UK
Dr. Matin Burrow, DMB-Diagnostics GmbH, Germany
Dr. Martin Kristensson, Visiopharm, Denmark
Glimpsesof16th
GlobalAnnualOncologistsMeeting
The success of the Oncologists 2017 conference has given us the
prospect to bring the gathering one more time. Conferenceseries
LLC hosted the “16th
Global Annual Oncologists Meeting” during
April 24-25, 2016 at JW Marriott Dubai, UAE
Theconferencewasembarkedwithanopeningceremonyfollowed
by Keynote sessions and followed by series of lectures delivered by
both Honorable Guests and members of the Keynote forum. The
adepts who promulgated the theme with their exquisite talk were:

4. Oncologists 2016 Testmonials
Diana Anderson
This was really a remarkable conference from oncologists 2016 where new advances and some new
methods and techniques looking in cancer were discussed in the meeting. I find this conference always
very interesting, these people comes from all over the world, The presentation are usually very good, I
think it’s very useful and worth full to attend omics conferences.
Stephanie Notttrott
I am glad to participate at Oncologists 2016 here at cologne, Germany. I am glad to participate at this
great meeting with very interesting talks from physician and expertise all over the world, and I have
enjoyed each and every sessions.
B R Das
I really enjoyed some of the talks and meeting people from all over the world, I am very happy to be a
part of this great meetings. The major interaction of this conference was about oncology what I like the
about this conference was the scientific sessions and this represents various countries.
Dr. Diana Anderson, University of Bradford, UK
Dr. Karl Reinhard Aigner, Medias Klinikum GmbH & Co KG,
Germany
Dr. Hirendranath Banerjee, Elizabeth City State University, USA
Dr. Ajay Singh, Mitchell Cancer Institute, USA
Dr. Matin Burrow, DMB-Diagnostics GmbH, Germany
Dr. Martin Kristensson, Visiopharm, Denmark
Glimpsesof10th
GlobalAnnualOncologistsMeeting
The success of the Oncologists 2016 conference has given us the
prospect to bring the gathering one more time. Conferenceseries
LLC hosted the “10th Global Annual Oncologists Meeting”
during July 11-13, 2016 at Park Inn by Radisson Köln City West,
Cologne, Germany
Theconferencewasembarkedwithanopeningceremonyfollowed
by Keynote sessions and followed by series of lectures delivered by
both Honorable Guests and members of the Keynote forum. The
adepts who promulgated the theme with their exquisite talk were:

5. Page 5
Keynote Forum
08:55-09:05 Introduction
09:05-09:35
Title: An Empirical Assay for Assessing Genomic Sensitivity and for Improving Cancer Diagnostics
Diana Anderson, University of Bradford, UK
09:35-10:05
Title: The Decline of the Incidence of Cancers during Organism Senescence
Alvaro Macieira-Coelho, French National Institute of Health (INSERM), France
10:05-10:35
Title: Anti-proliferative, anti-angiogenic and anti-metastatic effect of Emblica officinalis (Amla) on ovarian
cancer cells via microRNA regulated and autophagy mechanisms
Alok De, Kansas City VA Medical Center, USA
10:35-11:05
Title: Microfluidic platforms for isolating tumor cells from blood samples
Mohammad A. Qasaimeh, New York University, UAE
Coffee Break: 11:05-11:20 @ Pre Function Area
11:20-11:45
Title: Updates of HIPEC in colorectal carcinomatosis Principals and Review
Sadir Alrawi, Alzahra Cancer Center, UAE
11:45-12:10
Title: Cancer Treatment in the 20th Century are we close to a cure?
Ali Aldameh, Al Zahra cancer centre, UAE
Sessions:
Oncology | Organ Specific Cancer | Cancer Biomarkers
Session Chair: Jiri Vachtenheim, Charles University, Czech Republic
Session Co-chair: Eman Oweida, NMC Royal Hospital, UAE
Session Introduction
12:10-12:35
Title: Molecular spectra, frequencies, and distribution patterns of somatic mutations using next generation
sequencing in Arab women with breast cancer
Humaid O Al-Shamsi, The University of Texas, USA
12:35- 13:00
Title: Genetics in Oncology, Liquid Biopsy and Circulating Tumor DNA
Lina Abi Mosleh, Ayass Bioscience Inc., USA
13:00- 13:25
Title: All high risk? Pathologic extracapsular extension in the era of human papillomavirus associated
head/neck cancers
Tarek Dufan, American Hospital Dubai, UAE
Group Photo @ 13:25-13:35
Lunch Break: 13:35-14:35 @ Pre Function Area
14:35-15:00
Title: Evaluation of nonpalpable breast mass excision and sentinel node biopsy using radio-guided occult
lesion localization: A single-stage procedure
Timor Al-Alshee, King Abdulaah Medical City, Saudi Arabia
15:00-15:25
Title: The decrease of MITF, a crucial melanoma transcription factor does not induce marks of epithelial-
mesenchymal transition, maintains the proliferation and invasivity, but diminish the differentiation of
melanoma cells
Jiri Vachtenheim, Charles University, Czech Republic
15:25-15:50
Title: Lung Cancer Screening Indications and consensus Guidelines.
Ali Aldameh, Al Zahra cancer centre, UAE
08:00-08:30 Registrations
Day 1 April 24, 2017
Salon V
Opening Ceremony08:30-08:55conferenceseries.com

6. Page 6
15:50-16:15
Title: Exploiting nanomaterial-induced selective autophagy for enhanced clearance of intracellular
aggregate-prone proteins
Long-ping Wen, University of Science & Technology, China
16:15-16:40
Title: Non-V600 BRAF mutations define a distinct molecular subtype of metastatic colorectal cancer
Humaid O Al-Shamsi, The University of Texas, USA
Networking & Refreshment Break: 16:40-17:00 @ Pre Function Area
17:00-17:25
Title:Role of imaging in follow up of previously diagnosed and treated breast masses
Eman Oweida, NMC Royal Hospital, UAE
17:25-17:50
Title: Effects Of Natural Pigments On The Poly ( methyl methacrylate ) Biopolymer
Jaleel Kareem Ahmed, Babylon University, Iraq
17:50-18:15
Title:How to prevent chemotherapy medication errors?
Mahdi Shahriari, Shiraz University of Medical Sciences, Iran
Panel Disscussion
Day 2 April 25, 2017
Salon V
Keynote Forum
09:30-09:40 Introduction
09:40- 10:10
Title: Role of SPECT-CT imaging techniques in oncology
Sonya Sergieva, Sofia Cancer Center Sofia, Bulgaria
10:10-10:40
Title: Micro RNA (miRNA): Utility in oncology
Mohammed Y Almaghrabi, Prince Faisal Cancer Center, Saudi Arabia
10:40-11:10
Title: The design and properties of synthetic tissue/organ models
Ozge Akbulut, Sabanci University, Turkey
Coffee Break: 11:10-11:25 @ Pre Function Area
11:25-11:55
Title: Fertility sparing surgery in early stages of cervical cancer
Aleksandar Stefanović, Clinical Center of Serbia, Serbia
Sessions:
Cancer Causes | Cancer Diagnostics | Cancer Treatment and Therapy | Clinical Oncology
Session Chair: Ali Aldameh, Al Zahra cancer centre, UAE
Session Co-chair: Humaid O Al-Shamsi, The University of Texas, USA
11:55-12:20
Title: Urachal Carcinoma: multimodality treatment outcome, the MD Anderson experience, A retrospective
study
Humaid O Al-Shamsi, The University of Texas, USA
12:20-12:45
Title: Upper Gastrointestinal Surgery: National management trends and outcomes.
Ali Aldameh, Al Zahra cancer centre, UAE
12:45-13:10
Title: Fertility sparing approach in young patients with early stages of endometrial cancer
Katarina Jeremic, University of Belgrade, Serbia
13:10-13:35
Title: Regulation of LncRNA-MIF in c-Myc homeostasis
Mian Wu, University of Science and Technology of China, China
Lunch Break 13:35-14:35 @ Pre Function Area
14:35-15:00
Title: Religion/spiritual beliefs and oncology team who care for cancer patients
Mahdi Shahriari, Shiraz University of Medical Sciences, Iran
Special Session & Workshop By: Dr.Sadir Alrawi & Ozge Akbulut
15:00-15:45
Title: Silicone-based composites as surgical breast models for oncoplasty training
Sadir Alrawi, Alzahra Cancer Center, UAE
Ozge Akbulut, Sabanci University, Turkey

7. Page 7
Bookmark Your Dates
May 24-25, 2018 Osaka, Japan
22nd
Global Annual Oncologists Meeting
15:45-16:10
Title: From bench to bed: Impact of vitamin D3 replacement therapy on clinical outcomes and survival rates
in cancer patients
Mahdi Shahriari, Shiraz University of Medical Sciences, Iran
Networking & Refreshment Break: 16:10-16:30 @ Pre Function Area
Poster Presentation @ 16:30-17:30
ONC-01
Title: A study regarding the dermocosmetic care of cutaneous side-effects associated with chemotherapy
between breast cancer patients
Athanasia Varvaresou, Technological Educational Institute of Athens, Greece
ONC-02
Title: Functional assessment of quality of life using EORTC QLQ-CR29 in patients with colon cancer at King
Abdulaziz University Hospital
Ssakher M Al Otaibi, King Abdullah Medical City, Saudi Arabia
Abdullah Almoshadq, King Abdullah Medical City, Saudi Arabia
ONC-03
Title: Assessment of the level of knowledge about breast cancer related symptoms and treatment
Salma Abdullah Jabarty, King Khalid University, Saudi Arabia
Raghad Hamed Almusfir, King Khalid University, Saudi Arabia
ONC-04
Title: Dermocosmetic treatment for radiodermatitis in oncology patients
Athanasia Varvaresou, Technological Educational Institute of Athens, Greece
ONC-05
Title: Cytogenetic analysis in 101 Tunisian patients with de novo acute myeloid leukemia.
Hend Chaker, Pasteur Institute of Tunis, Tunisia
ONC-06
Title: CA125 and histological type of ovary cancer
Toufik Attouche, Pierre & Marie Curie Center, Algeria
ONC-07
Title: Inhibition of ovarian cancer stemness by silencing tumor-specific gene expression
Kyoungsook Park, Sungkyunkwan University, South Korea
Panel Discussion
Awards & Closing Ceremony

8. Page 8
Scientific Program 2016
Networking & Refreshment Break
Session Introduction
Session 1: Oncology & Organ Specific Cancer
Session Chair: Ajay Singh, Mitchell Cancer Institute, USA
Session Co-Chair: Stephanie Notttrott, Isenbruck Bösl Hörschler LLP, Germany
Title: Understanding and overcoming chemoresistance of pancreatic cancer
Ajay Singh, Mitchell Cancer Institute, USA
Title: Patent protection for diagnostics and therapeutics - The essentials and importance of second medical use patents in
precision medicine
Stephanie Notttrott, Isenbruck Bösl Hörschler LLP, Germany
Title: The chemopreventive potential of silver nanoparticles against UVB-induced skin carcinogenesis
Seema Singh, Mitchell Cancer Institute, USA
VP: Perioperative use of NSAID might prevent early relapses in breast and other cancers: An upstream approach
Michael Retsky, Harvard TH Chan School of Public Health, USA
Group Photo 12:50-13:00
Lunch Break
Title: Human borna disease virus infection impacts host proteome and histone lysine acetylation in human oligodendroglia
cells
Xia Liu, Institute of Forensic Science, China
Title: Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of
gemcitabine
Yan-Shen Shan, Cheng Kung University, Taiwan
Title: Evaluation of actionable mutation (KRAS, BRAF and PIK3CA) in colon cancer: Determination of frequency,
distribution pattern in Indian patients
B R Das, Research and Development, SRL Ltd., India
Title: Challenges in treating Ca Nasopharynx, Ca Tonsil and post op Head neck cancers by Intensity Modulated
Radiationtherapy
Anitha Gopal, Fortis hospitals, India
Title: One-step mixing with anti-tumor/anti-CD3 bispecific antibody enhances tumor targeting and therapeutic efficacy of
ex vivo expanded T cells
Kuo-Hsiang Chuang, Taipei Medical University, Taiwan
Networking & Refreshment Break
Title: Dendritic cell vaccine therapy in breast cancer patients
Yathish Kumar, Karnataka cancer hopsital & research centre, India
Title: Revisiting the value and role of anti-angiogenesis in solid tumors and the mechanism to inhibit angiogenesis, and
their possible complications: Pediatric oncologists view.
Mahdi Shahriari, Shiraz University of Medical Sciences, Iran
Title: Absence of the FANCM c.5101C>T mutation in BRCA1/2-negative triple-negative breast cancer patients from
Pakistan
Muhammad U Rashid, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Pakistan
Keynote Forum
Introduction
Title: Sensitivity and specificity of the empirical Lymphocyte Genome Sensitivity (LGS) assay:
Implications for improving cancer diagnostics
Diana Anderson, University of Bradford, UK
Title: Optimizing HER2 assessment in breast cancer - Application of automated image analysis
Martin Kristensson, Visiopharm, Denmark
July 11-13, 2016 Dubai, UAE
10th
GlobalAnnualOncologistsMeeting

9. Page 9
Day 2 July 12, 2016
Keynote Forum
Introduction
Title: Isolated Thoracic Perfusion with Chemofiltration (ITP-F) breaks through drug
resistance in progressive and pretreated malignant pleural mesothelioma
Karl R Aigner, Medias Klinikum GmbH & Co KG, Germany
Title: New method of quantitative, circulating tumor cell (CTC) diagnostic, treatment
selection, monitoring and surveillance with superior outcome for the patient
Matin Burrow, DMB-Diagnostics GmbH, Germany
Networking & Refreshment Break
Session 2: Cancer Causes, Cancer Diagnostics, Cancer Treatment and Therapy & Clinical Oncology
Session Introduction
Session Chair: Diana Anderson, University of Bradford, UK
Session Co-Chair: Apollon Karseladze, N. Blokhin Cancer Research Center, Russian Federation
Title: General overview of the Comet assay
Diana Anderson, University of Bradford, UK
Title: The march of pathologists into ‘Big Industry’ or the worries of a newly transformed surgical pathologist
Diana Stanoeva, Histogenex, Belgium
Title: Impairment of vascularization of the surface covering epithelium induces ischemia and promotes malignization: A
new hypothesis of a possible mechanism of cancer pathogenesis
Apollon Karseladze, N. Blokhin Cancer Research Center, Russian Federation
Title: Cholesterol Import and steroidogenesis are Biosignatures for gastric cancer progression
Wen-Lung Ma, China Medical University Hospital, Taiwan
Lunch Break
Poster Presentation
Title: Z-BeEAM (Ibritumomab tiuxetan, Bendamustine, Etoposide, Cytarabine, Melphalan) before autologous stem cell
transplantation is safe and efficient for refractory large B-cell lymphoma
Magalie Tardy, Centre Antoine Lacassagne, France
Title: The fetal risks from diagnostic use of radiation during pregnancy: A systematic review and proposal of a clinical
protocol
Mafalda Sofia Barros Gomes, Centro Hospitalar do Porto, Portugal
Title: Prognostic factors and their correlation with staging in patients with Multiple Myeloma: A single centre study in
North India
Tanvi Sood, Shri Ram Murti Smarak Institute of Medical Sciences, India
VP: MicroRNA-21 expression in primary breast cancer tissue among female patients and its correlation with chromosome
17 aneusomy
Noura Ramadan, Suez Canal University, Egypt
Title: Combined bevacizumab and stereotactic radiosurgery for the treatment of a child with recurrent medulloblastoma
Ming Zhao, Chinese PLA General Hospital, China
Keynote Forum
Keynote Presenation by Hirendra Nath Banerjee
Elizabeth City State University, USA
Networking & Refreshment Break
Award Ceremony
Day 3 July 13, 2016
Extended Networking Session & Lunch
Bookmark your dates
April 24-25, 2017 Dubai, UAE
16th
Global Annual Oncologists Meeting

10. Tentative Agenda
May 24, 2018 Day 1
Opening Ceremony
Honorable Guests Speech
Keynote Forum
Panel Discussion
Group Photo
Coffee Break
Speaker Forum
Oncology
Clinical Oncology
Pediatric Oncology
Radiation Oncology
Panel Discussion
Lunch Break
"Speaker Forum (Cont...)"
Hematology Oncology
Chemotherapy
Oncologists
Panel Discussion
*Young Researcher Forum
Panel Discussion
Awards Ceremony
Cancer : Vaccines and Prevention
Cancer Prognosis
Cancer and Alternative Medicine
Economic Impact on Cancer
Oncology Case reports
May 25, 2018 Day 2
Keynote Forum
Panel Discussion
Coffee Break
Speaker Forum
Organ Specific Cancer
Cancer Diagnostics Market
Cancer: Diagnostics and Staging
Coffee Break
Panel Discussion
Speaker Forum (Cont...)
Cancer: Treatment and Therapy
Cancer Biomarkers
Cancer and Pharmacology
Best Poster Evaluation
Awards Ceremony
"Award Ceremony
Closing Ceremony"
Chemotherapy
Oncologists
Cancer Nursing and Care
Entreprenuers Investment Meet
Panel Discussion
*Young Researcher Forum
Poster Session & Coffee Break
* Exclusive Exhibitor Event
* Networking Event
Note: Conference schedule is subject to change.
Note: Workshops and Symposia slots are available. To book slot for
Workshop and Symposium send us the proposal.
Call for Abstract : http://annualmeeting.conferenceseries.com/oncologists/call-for-abstracts.php
Registration : http://annualmeeting.conferenceseries.com/oncologists/registration.php
Abstract Submission : http://annualmeeting.conferenceseries.com/oncologists/abstract-submission.php
E-Poster : http://annualmeeting.conferenceseries.com/oncologists/eposter-presentation.php

11. • Oncology
• Clinical Oncology
• Pediatric Oncology
• Radiation Oncology
• Hematology Oncology
• Chemotherapy
• Oncologists
• Organ Specific Cancer
• Cancer : Causes
• Cancer: Diagnostics and Staging
• Cancer: Treatment and Therapy
• Cancer Biomarkers
• Cancer and Pharmacology
• Cancer : Vaccines and Prevention
• Cancer Prognosis
• Cancer and Alternative Medicine
• Economic Impact on Cancer
• Oncology Case reports
• Cancer Nursing and Care
• Entreprenuers Investment Meet
• Cancer Diagnostics Market
• Cancer Screening Tests
• Oncogenomics & Oncoproteomics
• Cancer Pharma IndustryComprehensive
Geriatric Oncology
• Cancer Biopsy
Conference Highlights
Video presentation: You can send us the recorded video of your presentation which will be
played during the time of conference , as we are having live streaming for the conference
you can directly interact with the speakers, delegates and all participants.
E-poster: You can share your research in the form of e- poster which will be displayed on the
conference website.
Poster Presentation: Besides that your poster can be send to our conference, which will be
displayed during the poster presentation session
Young Researchers Forum : The Young Researchers Forum offers young researchers the
possibility to meet and discuss research topics and methodologies, share and develop ideas,
learn from each other and gain knowledge from senior researchers.
Selected contributions will be published in following Conferenceseries LLC Journals
• Journal of Cancer Science & Therapy
• Chemotherapy: Open Access
• Journal of Integrative Oncology
• Advances in Oncology Research and Treatments
• Journal of Leukemia
Opportunities

12. Why Must Attend
Acadmicians Opportunities
• Speaker Presentations
• Symposium /Workshop
• Live streaming
• All attendees can avail CPD Credits (Continuing Professional Development)/ CME Credits
• All Participants will receive certification by the International Organizing Committee
• Global Networking Opportunities
• All accepted abstracts will be published in the respective Journals
For Students and Young Researchers
• Poster Competition
• All Participants will receive certification by the International Organizing Committee
• Young Researcher Forum Award to the best presenter
• Group registrations
For Business Delegates
• Corporate workshop
• Book Launch event
• Networking opportunities
For Product Manufacturers
• Sponsorships opportunities
• Exhibition Booth
• Brand Promotion
• Product launch
• Corporate workshop
• Scientific Partnering
• B2B Meeting
• Marketing and Networking with clients
Be a Sponsor at Oncologists 2017
• Elite Sponsor
• Gold Sponsor
• Silver Sponsor
• Exhibition
• Additional Sponsorship Packages
• Lunch / Cocktail Sponsor
• Coffee Break Sponsor
• Conference Delegate Bag Sponsor
• Bag Insert Sponsor
• Lanyard (also known as neck cords)
• Advertisements
• Outside Back Cover (color)
• Inside Front Cover (color)
• Inside Back Cover (color)

13. Japan is an archipelago in the Pacific region. It is separated from the east coast of Asia by the
Sea of Japan. It consists of a great string of islands in a northeast-southwest arc that stretches
for approximately 1,500 miles (2,400 km) through the western North Pacific Ocean. Nearly the
entire land area is taken up by the country’s four main islands; from north to south these are
Hokkaido (Hokkaidō), Honshu (Honshū), Shikoku, and Kyushu (Kyūshū). Japanese economy
grew very quickly and it serves as a major economic power in the world. Much of this growth
resulted in increase in worker productivity. This higher productivity was due mainly to: increased
capital (machines, etc.) per worker, advance in technology, a highly educated and skilled labor
force, supportive government policies and a good world trade environment.
With a population of 127 million, a rapidly aging society, high per capita income, and a life
expectancyrateofover80years,Japanrepresentsahugemarketformedicaldevicemanufacturers
looking to expand sales in Asia. The medical device market size is estimated at $31 billion, and it is
projected to maintain a steady annual growth rate of 3% as the Japanese population continues to
age.Japanesecitizensstillenjoyverylonglivesandafirstclasshealthcaresystem,cancerrepresents
a significant challenge for scientists and doctors. The Japanese government has taken deliberate
steps towards addressing the rising rate of cancer, and medical device companies. Responding to
growing worldwide demand, Japanese manufactures have been at the forefront of developing new
types of cancer radiation therapy. Particle-beam radiotherapy the new treatment carries a smaller
physical and financial burden on the patient, meaning it can be used by outpatients. . Japan has
been a pioneer in the field of heavy-ion beam technology. Mitsubishi Electric, Hitachi and Toshiba
are the world’s only manufactures of treatment systems based on heavy-ion beams.
About Osaka
Oncologists
2018

14. Dōjima River
Namba Parks
Osaka Dome
Sakishima Building
Minami Temma Park
National Museum of Art
Osaka Jo Hall
Tempozan Ferris Wheel
Nagai Botanical Garden
Osaka Aquarium
Universal Studios Japan
Tennoji Park
Nakanoshima Osaka Castle
Osaka Science Museum
Nakanoshima
Tempozan Ferris Wheel Tennōji Zoo
City Attractions

15. Venue
Osaka, Japan
Hyatt Regency Osaka
1-13-11 Nanko-kita
Suminoe-ku Osaka Japan 559-0034
Contact Us
Cristina Fernandez
Tel: 1-650-889-4686; Fax: +1-650-618-1417
Email oncologyconference@cancersummit.org
oncologymeet@oncologymeet.com
C
o
n
ta
c
t
u
s
conferenceseries.com
http://annualmeeting.conferenceseries.com/oncologists/
Important Dates
Abstract submission opens: May 10, 2017
Registration opens: June 22, 2017
Early bird registration: August 15, 2017
On spot registration: May 24, 2018
Oncologists
2018